Cargando…

Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries

INTRODUCTION: Estimating the value of providing effective healthcare interventions in a country requires an assessment of whether the improvement in health outcomes they offer exceeds the improvement in health that would have been possible if the resources required had, instead, been made available...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ochalek, Jessica, Abbas, Kaja, Claxton, Karl, Jit, Mark, Lomas, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577028/ https://www.ncbi.nlm.nih.gov/pubmed/33082132 http://dx.doi.org/10.1136/bmjgh-2020-003006

Ejemplares similares

Accounting for country- and time-specific values in the economic evaluation of health-related projects relevant to low- and middle-income countries
por: Lomas, James, et al.
Publicado: (2021)

Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data
por: Ochalek, Jessica, et al.
Publicado: (2018)

Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study
por: Debellut, Frédéric, et al.
Publicado: (2021)

Health and economic impact of rotavirus vaccination in GAVI-eligible countries
por: Kim, Sun-Young, et al.
Publicado: (2010)

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models
por: Jit, Mark, et al.
Publicado: (2011)

Costs of Introducing and Delivering HPV Vaccines in Low and Lower Middle Income Countries: Inputs for GAVI Policy on Introduction Grant Support to Countries
por: Levin, Ann, et al.
Publicado: (2014)

Impact and cost-effectiveness of measles vaccination through microarray patches in 70 low-income and middle-income countries: mathematical modelling and early-stage economic evaluation
por: Fu, Han, et al.
Publicado: (2023)

Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country
por: Burger, Emily A., et al.
Publicado: (2018)

What works for human papillomavirus vaccine introduction in low and middle-income countries?
por: Howard, Natasha, et al.
Publicado: (2017)

How to evaluate the implementation of complex health programmes in low-income settings: the approach of the Gavi Full Country Evaluations
por: Soi, Caroline, et al.
Publicado: (2020)

Screening for Human Papillomavirus in a Low- and Middle-Income Country
por: Atkinson, Aaron E., et al.
Publicado: (2019)

Cost-effectiveness of measles and rubella elimination in low-income and middle-income countries
por: Levin, Ann, et al.
Publicado: (2023)

Rotavirus vaccine protection in low-income and middle-income countries
por: Ramakrishnan, Girija, et al.
Publicado: (2019)

Improving childhood vaccination in low-income and middle-income countries
por: eBioMedicine
Publicado: (2023)

The value of demonstration projects for new interventions: The case of human papillomavirus vaccine introduction in low- and middle-income countries
por: Howard, N., et al.
Publicado: (2016)

Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis
por: Drolet, Mélanie, et al.
Publicado: (2021)

Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis
por: Dorji, Thinley, et al.
Publicado: (2021)

Human papillomavirus vaccination in low- and middle-income countries: progression, barriers, and future prospective
por: Ebrahimi, Narges, et al.
Publicado: (2023)

Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical modelling analysis
por: Bénard, Élodie, et al.
Publicado: (2022)

Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007–2016
por: Gallagher, Katherine E., et al.
Publicado: (2017)

Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries
por: Gallagher, Katherine E., et al.
Publicado: (2017)

The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countries
por: Portnoy, Allison, et al.
Publicado: (2023)

Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study
por: Bilcke, Joke, et al.
Publicado: (2019)

Vaccine equity in low and middle income countries: a systematic review and meta-analysis
por: Ali, Huda Ahmed, et al.
Publicado: (2022)

Do existing research summaries on health systems match immunisation managers' needs in middle- and low-income countries? Analysis of GAVI health systems strengthening support
por: Bosch-Capblanch, Xavier, et al.
Publicado: (2011)

Vaccines against human papillomavirus in low and middle income countries: a review of safety, immunogenicity and efficacy
por: Nakalembe, Miriam, et al.
Publicado: (2015)

Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries
por: Deogaonkar, Rohan, et al.
Publicado: (2012)

Vaccine manufacturing capacity in low- and middle-income countries
por: Khan, Mohammed Imran, et al.
Publicado: (2021)

Potential population-level effectiveness of one-dose HPV vaccination in low-income and middle-income countries: a mathematical modelling analysis
por: Bénard, Élodie, et al.
Publicado: (2023)

Correction: Vaccine equity in low and middle income countries: a systematic review and meta-analysis
por: Ahmed Ali, Huda, et al.
Publicado: (2022)

Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics
Publicado: (2021)

COVID-19 vaccines pricing policy options for low-income and middle- income countries
por: Guzman, Javier, et al.
Publicado: (2021)

Valuing Changes in Time Use in Low- and Middle-Income Countries
por: Whittington, Dale, et al.
Publicado: (2018)

The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study
por: Clark, Rebecca A, et al.
Publicado: (2023)

Management of neonatal jaundice in low-income and middle-income countries
por: Erdeve, Omer
Publicado: (2020)

Tackling antimicrobial resistance in low-income and middle-income countries
por: Pokharel, Sunil, et al.
Publicado: (2019)

Estimates of case-fatality ratios of measles in low-income and middle-income countries: a systematic review and modelling analysis
por: Portnoy, Allison, et al.
Publicado: (2019)

Human papillomavirus (HPV) vaccine implementation in low and middle-income countries (LMICs): Health system experiences and prospects()
por: Wigle, Jannah, et al.
Publicado: (2013)

Social mobilisation, consent and acceptability: a review of human papillomavirus vaccination procedures in low and middle-income countries
por: Kabakama, Severin, et al.
Publicado: (2016)

The potential effect of improved provision of rabies post-exposure prophylaxis in Gavi-eligible countries: a modelling study
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sk7mog3perfjobstqt02s027qv